223 related articles for article (PubMed ID: 26175116)
21. Feasibility of in vivo
Bucerius J; Barthel H; Tiepolt S; Werner P; Sluimer JC; Wildberger JE; Patt M; Hesse S; Gertz HJ; Biessen EAL; Mottaghy FM; Sabri O
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1119-1128. PubMed ID: 28321471
[TBL] [Abstract][Full Text] [Related]
22. The Incremental Diagnostic Value of [18F]Florbetaben PET and the Pivotal Role of the Neuropsychological Assessment in Clinical Practice.
Spallazzi M; Barocco F; Michelini G; Morelli N; Scarlattei M; Baldari G; Ruffini L; Caffarra P
J Alzheimers Dis; 2019; 67(4):1235-1244. PubMed ID: 30689568
[TBL] [Abstract][Full Text] [Related]
23. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
Fodero-Tavoletti MT; Brockschnieder D; Villemagne VL; Martin L; Connor AR; Thiele A; Berndt M; McLean CA; Krause S; Rowe CC; Masters CL; Dinkelborg L; Dyrks T; Cappai R
Nucl Med Biol; 2012 Oct; 39(7):1042-8. PubMed ID: 22503458
[TBL] [Abstract][Full Text] [Related]
25. Comparison of
Doré V; Bullich S; Rowe CC; Bourgeat P; Konate S; Sabri O; Stephens AW; Barthel H; Fripp J; Masters CL; Dinkelborg L; Salvado O; Villemagne VL; De Santi S
Alzheimers Dement; 2019 Jun; 15(6):807-816. PubMed ID: 31101517
[TBL] [Abstract][Full Text] [Related]
26. Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.
Seibyl J; Catafau AM; Barthel H; Ishii K; Rowe CC; Leverenz JB; Ghetti B; Ironside JW; Takao M; Akatsu H; Murayama S; Bullich S; Mueller A; Koglin N; Schulz-Schaeffer WJ; Hoffmann A; Sabbagh MN; Stephens AW; Sabri O
J Nucl Med; 2016 Jun; 57(6):900-6. PubMed ID: 26823561
[TBL] [Abstract][Full Text] [Related]
27. Early-Frame [
Fettahoglu A; Zhao M; Khalighi M; Vossler H; Jovin M; Davidzon G; Zeineh M; Boada F; Mormino E; Henderson VW; Moseley M; Chen KT; Zaharchuk G
J Nucl Med; 2024 Feb; 65(2):306-312. PubMed ID: 38071587
[TBL] [Abstract][Full Text] [Related]
28. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M
Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118
[TBL] [Abstract][Full Text] [Related]
29. Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.
Sabbagh MN; Schäuble B; Anand K; Richards D; Murayama S; Akatsu H; Takao M; Rowe CC; Masters CL; Barthel H; Gertz HJ; Peters O; Rasgon N; Jovalekic A; Sabri O; Schulz-Schaeffer WJ; Seibyl J
J Alzheimers Dis; 2017; 56(2):441-446. PubMed ID: 27983552
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.
Segovia F; Gómez-Río M; Sánchez-Vañó R; Górriz JM; Ramírez J; Triviño-Ibáñez E; Carnero-Pardo C; Martínez-Lozano MD; Sopena-Novales P
J Alzheimers Dis; 2018; 65(3):765-779. PubMed ID: 30103321
[TBL] [Abstract][Full Text] [Related]
31. Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer's disease and healthy volunteers.
Tiepolt S; Barthel H; Butzke D; Hesse S; Patt M; Gertz HJ; Reininger C; Sabri O
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):238-44. PubMed ID: 23104671
[TBL] [Abstract][Full Text] [Related]
32. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.
Villemagne VL; Ong K; Mulligan RS; Holl G; Pejoska S; Jones G; O'Keefe G; Ackerman U; Tochon-Danguy H; Chan JG; Reininger CB; Fels L; Putz B; Rohde B; Masters CL; Rowe CC
J Nucl Med; 2011 Aug; 52(8):1210-7. PubMed ID: 21764791
[TBL] [Abstract][Full Text] [Related]
33. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
[TBL] [Abstract][Full Text] [Related]
34. Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects.
Senda M; Sasaki M; Yamane T; Shimizu K; Patt M; Barthel H; Sattler B; Nagasawa T; Schultze-Mosgau M; Aitoku Y; Dinkelborg L; Sabri O
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):89-96. PubMed ID: 25143073
[TBL] [Abstract][Full Text] [Related]
35. Implementing the centiloid transformation for
Bourgeat P; Doré V; Fripp J; Ames D; Masters CL; Salvado O; Villemagne VL; Rowe CC;
Neuroimage; 2018 Dec; 183():387-393. PubMed ID: 30130643
[TBL] [Abstract][Full Text] [Related]
36. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
de Lartigue J
Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
[TBL] [Abstract][Full Text] [Related]
37. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
38. Parametric imaging of dual-time window [
Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
[TBL] [Abstract][Full Text] [Related]
39. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
Young P; Heeman F; Axelsson J; Collij LE; Hitzel A; Sanaat A; Niñerola-Baizan A; Perissinotti A; Lubberink M; Frisoni GB; Zaidi H; Barkhof F; Farrar G; Baker S; Gispert JD; Garibotto V; Rieckmann A; Schöll M;
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):734-748. PubMed ID: 37897616
[TBL] [Abstract][Full Text] [Related]
40. Beta-amyloid imaging with florbetaben.
Sabri O; Seibyl J; Rowe C; Barthel H
Clin Transl Imaging; 2015; 3(1):13-26. PubMed ID: 25741488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
